Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New test helps assess stroke Patients' thinking, even if they Can't speak

NCT ID NCT01904799

Diagnosis Sponsor: Centre Hospitalier Universitaire Dijon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new thinking test called CASP for stroke patients. The test is designed to work even for patients who have trouble speaking after a stroke. Researchers checked how well the test works by comparing it to other tests in 263 patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cognitive Assessment for Stroke Patients (CASP) test
What this could lead to
If successful, this test could help doctors quickly check thinking skills in stroke patients, even those who have trouble speaking.
What could go wrong
This is a completed study testing a new test, not a treatment. The test may not be accurate for all patients or widely adopted.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

263 people

The number who actually took part.

Started

Jan 2015

Finished

Mar 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: For CVA patients * patients hospitalised in rehabilitation after a first recent hemispheric CVA (less than 6 weeks) ; * aged \> 18; * absence of severe disorders of oral comprehension (BDAE aphasia severity score \>2 for comprehension); * whatever the severity of oral expression disorders; * who have been given clear written and oral information, and after the doctor has verified their ability to understand the protocol. For " Control " patients (to evaluate divergent validity) * patients hospitalised in rehabilitation units or geriatrics taking part in this study; * aged \> 18. Exclusion Criteria: For CVA patients * patients who do not speak French; * cognitive disorders known before the CVA; * psychotic disorders known before the CVA; * major visual disorders incompatible with reading, known before the CVA. For " Control " patients (to evaluate divergent validity) * patients who do not speak French; * cognitive disorders known before the CVA; * psychotic disorders known before the CVA; * major visual disorders incompatible with reading, known before the CVA.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke

Contacts and locations

Locations

  • CHU de Dijon

    Dijon, 21079, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.